Evolution of the Average Target: Dolby Laboratories, Inc.

Evolution of the Target Price: Dolby Laboratories, Inc.

Changes in Analyst Recommendations: Dolby Laboratories, Inc.

3e954cc533e1701e78d0c0f.9vjjkhRCI2T2wULg3mn4wvcJFC9e0KWyGBr_FEIEons.nLqp1CAxcjWxjXGh6CrVkrBGJ0I84NfLbHKHLAB11E6unazNIidIO6GuBw~5df284eb4dc5c27b3b8b7f9e02c7e4be
11-19 Barrington Trims Price Target on Dolby Laboratories to $95 From $100, Keeps Outperform Rating MT
05/09/25 Baird Initiates Dolby Laboratories at Neutral With $74 Price Target MT
15/08/25 Dolby Laboratories' Immersive Media Innovation, Strategic Partnerships to Drive Long-Term Growth, Tigress Financial Partners Says MT
15/08/25 Tigress Adjusts Price Target on Dolby Laboratories to $114 From $112, Maintains Buy Rating MT
03/06/24 Barrington Upgrades Dolby Laboratories to Outperform From Market Perform, Price Target is $100 MT
04/08/23 Rosenblatt Adjusts Price Target on Dolby Laboratories to $98 From $93, Maintains Buy Rating MT
03/02/23 Rosenblatt Adjusts Price Target on Dolby Laboratories to $90 From $85, Maintains Buy Rating MT
18/11/22 Barrington Downgrades Dolby Laboratories to Market Perform From Outperform as Economic Challenges Results in Lower Volumes MT
18/11/22 Barrington Downgrades Dolby Laboratories to Market Perform From Outperform MT
07/11/22 Rosenblatt Adjusts Price Target on Dolby Laboratories to $85 From $90, Maintains Buy Rating MT
14/10/22 Tigress Financial Cuts Dolby Laboratories' Price Target to $116 From $128 'on Near-Term Valuation Rerating;' Buy Rating Kept MT
24/05/22 Rosenblatt Starts Dolby Laboratories at Buy With $90 Price Target MT
12/05/22 Barrington Research Lowers Price Target for Dolby Laboratories to $90 From $115, Maintains Outperform Rating MT
02/08/21 DOLBY LABORATORIES : Barrington Upgrades Dolby Laboratories to Outperform From Market Perform "as New Initiatives Supplement Progress", Sets $115 Price Target MT
29/01/21 DOLBY LABORATORIES : B. Riley Adjusts Dolby Laboratories' Price Target to $89 From $79, Keeps Neutral Rating MT
04/01/21 DOLBY LABORATORIES : Barrington Research Downgrades Dolby Laboratories to Market Perform From Outperform MT
13/11/20 DOLBY LABORATORIES : JP Morgan Adjusts Price Target for Dolby Laboratories to $90 From $78, Maintains Overweight Rating MT
13/11/20 DOLBY LABORATORIES : B. Riley Adjusts Dolby Laboratories' Price Target to $79 from $73, Keeps Neutral Rating MT
13/11/20 DOLBY LABORATORIES : Barrington Research Adjusts PT on Dolby Laboratories to $95 From $83, Citing 'Meaningful Positive Momentum;' Outperform Rating Kept MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+52.91%
+55.21%
+29.09%
+47.35%
- - +50.24%
+48.24%
Average +47.17%
Weighted average by Cap. +49.12%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
51.23USD
Average target price
78.33USD
Spread / Average Target
+52.91%
High Price Target
90.00USD
Spread / Highest target
+75.68%
Low Price Target
60.00USD
Spread / Lowest Target
+17.12%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Barrington Research
Baird
Tigress Financial
Rosenblatt Securities
B. Riley
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
51.23USD
Average target price
78.33USD
Spread / Average Target
+52.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DLB Stock
  4. Consensus Dolby Laboratories, Inc.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!